Pharmacists’ role in detection and evaluation of adverse drug reactions: Developing proactive systems for pharmacosurveillance
American Journal of Health-System Pharmacy · 2023
DOI: 10.1093/ajhp/zxac325 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2023. Verfasst von Alejandra Salazar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, and Boston Medical Center, Boston, MA, USA. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Medical Informatics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Gordon and Betty Moore Foundation.
Abstract (Originalsprache)
Purpose
To identify current challenges in detection of medication-related symptoms, and review technology-based opportunities to increase the patient-centeredness of postmarketing pharmacosurveillance to promote more accountable, safer, patient-friendly, and equitable medication prescribing. Summary Pharmacists have an important role to play in detection and evaluation of adverse drug reactions (ADRs). The pharmacist’s role in medication management should extend beyond simply dispensing drugs, and this article delineates the rationale and proactive approaches for pharmacist detection and assessment of ADRs. We describe a stepwise approach for assessment, best practices, and lessons learned from a pharmacist-led randomized trial, the CEDAR (Calling for Detection of Adverse Drug Reactions) project.
Conclusion
Health systems need to be redesigned to more fully utilize health information technologies and pharmacists in detecting and responding to ADRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, and Boston Medical Center, Boston, MA, USA.
- Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, and MCPH University, Boston, MA, USA.
- Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, and Dana Farber Cancer Institute, Boston, MA, USA.
- School of Public Health, Haifa University, Haifa, Israel.
- Nursing School, Zefat Academic College, Zefat, Israel.
- Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Förderung
- Gordon and Betty Moore Foundation
Zitieren
APA
Salazar, A., Amato, M. G., Shah, S. N., Khazen, M., Aminmozaffari, S., Klinger, E. V., Volk, L. A., Mirica, M., & Schiff, G. D. (2023). Pharmacists’ role in detection and evaluation of adverse drug reactions: Developing proactive systems for pharmacosurveillance. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxac325
Vancouver
Salazar A, Amato MG, Shah SN, Khazen M, Aminmozaffari S, Klinger EV, et al. Pharmacists’ role in detection and evaluation of adverse drug reactions: Developing proactive systems for pharmacosurveillance. American Journal of Health-System Pharmacy. 2023. doi:10.1093/ajhp/zxac325
BibTeX
@article{Salazar2023,
author = {Salazar, Alejandra and Amato, Mary G and Shah, Sonam N and Khazen, Maram and Aminmozaffari, Saina and Klinger, Elissa V and Volk, Lynn A and Mirica, Maria and Schiff, Gordon D},
title = {Pharmacists’ role in detection and evaluation of adverse drug reactions: Developing proactive systems for pharmacosurveillance},
journal = {American Journal of Health-System Pharmacy},
year = {2023},
doi = {10.1093/ajhp/zxac325}
}
EUVIMED